Home/Filings/4/0001062993-24-003497
4//SEC Filing

Desai Kirti 4

Accession 0001062993-24-003497

CIK 0001860871other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:30 PM ET

Size

5.0 KB

Accession

0001062993-24-003497

Insider Transaction Report

Form 4
Period: 2024-02-14
Desai Kirti
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-02-14+9,696,1869,696,186 total
Footnotes (1)
  • [F1]On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc ("Tevogen"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer.

Issuer

Tevogen Bio Holdings Inc.

CIK 0001860871

Entity typeother

Related Parties

1
  • filerCIK 0002011765

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:30 PM ET
Size
5.0 KB